anayamalik, Author at European Medical Journal - Page 56 of 83

Dementia "Diagnosis Unawareness" Highs of 85% in New Study

In Nueces County, Texas, researchers uncovered troubling insights into dementia diagnosis awareness among a diverse population.

High Costs Cause One in Six Adults to Stop Asthma Medication

Financial barriers to asthma medications continue to compromise patient outcomes, increasing the risk of asthma attacks and emergency room visits, according to a recent analysis spanning 2011 to 2022.

Stark Sex Differences in Long COVID Risk

Females are at significantly higher risk of developing long COVID compared to males, according to a recent cohort study involving over 12,000 participants.

Acne Improvements in the First 4 Weeks of Treatment

Fixed-combination topical therapies show improvements in acne within the first 4 weeks of treatment, according to new data compiled from pivotal clinical trials.

Anti-Inflammatory Drugs Linked to Lower Parkinson’s Risk

New research published highlights a potential link between anti-inflammatory treatments and a reduced risk of Parkinson’s disease (PD) in patients with autoimmune disorders.

Checkpoint Myocarditis: A Breakthrough in Immune Insights

Immune checkpoint inhibitors, widely used in cancer therapy, have revolutionized oncology but come with the risk of severe immune-related adverse events, including checkpoint myocarditis.

New COPD Screening Method Enhances Detection

Discover how a polygenic risk score enhances traditional methods for identifying undiagnosed COPD in at-risk populations, offering a significant step forward in diagnosis.

Sharp Surge in Pediatric Head Infections Since Pandemic

The incidence of serious head and neck infections (HNI) among children in the United States has surged dramatically since 2021, according to a new study.

Lifestyle Care Favored Over Guidelines for Back Pain

A recent randomized clinical trial has demonstrated that incorporating healthy lifestyle care into chronic low back pain management can provide small but meaningful improvements in disability, weight loss, and quality of life.

Breakthrough Trial Spotlights Skin Fragility of the Arms

A groundbreaking clinical trial has provided valuable insights into the management of dermatoporosis, a condition characterized by chronic extracellular matrix (ECM) degradation leading to skin atrophy and fragility.